These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8508356)

  • 1. Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications.
    Bodian CA; Perzin KH; Lattes R; Hoffmann P
    Cancer; 1993 Jun; 71(12):3908-13. PubMed ID: 8508356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of benign proliferative breast disease.
    Bodian CA; Perzin KH; Lattes R; Hoffmann P; Abernathy TG
    Cancer; 1993 Jun; 71(12):3896-907. PubMed ID: 8389654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign breast disease and cancer risk.
    Bianchi S; Palli D; Galli M; Zampi G
    Crit Rev Oncol Hematol; 1993 Dec; 15(3):221-42. PubMed ID: 8142058
    [No Abstract]   [Full Text] [Related]  

  • 6. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE
    West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benign and premalignant breast lesions--clinico-pathological correlation].
    Afek A; Shibi R; Kopolovitz G
    Harefuah; 1997 Nov; 133(9):375-8. PubMed ID: 9418343
    [No Abstract]   [Full Text] [Related]  

  • 8. A pathologic study of benign breast diseases in Tokyo and New York.
    Schuerch C; Rosen PP; Hirota T; Itabashi M; Yamamoto H; Kinne DW; Beattie EJ
    Cancer; 1982 Nov; 50(9):1899-903. PubMed ID: 7116314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Small focal lesions of the breast: a clinico-morphological analysis].
    Serov VV; Kuzin MI; Zolotarevskiĭ VB; Zal'tsman IN; Kulakova AM
    Arkh Patol; 1984; 46(9):25-32. PubMed ID: 6095796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical apocrine adenosis diagnosed on breast core biopsy: implications for management.
    Calhoun BC; Booth CN
    Hum Pathol; 2014 Oct; 45(10):2130-5. PubMed ID: 25106711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histologic classification of breast cancer and its precancerous stages].
    Nizze H
    Zentralbl Gynakol; 1987; 109(1):3-14. PubMed ID: 3033949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary duct proliferation in the elderly. A histopathologic study.
    Kramer WM; Rush BF
    Cancer; 1973 Jan; 31(1):130-7. PubMed ID: 4345607
    [No Abstract]   [Full Text] [Related]  

  • 15. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
    Dauplat MM; Penault-Llorca F
    Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathology of premalignant and malignant diseases of the female breast].
    Prechtel K
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.
    Kabat GC; Jones JG; Olson N; Negassa A; Duggan C; Ginsberg M; Kandel RA; Glass AG; Rohan TE
    Cancer Causes Control; 2010 Jun; 21(6):821-8. PubMed ID: 20084540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy.
    Neal L; Sandhu NP; Hieken TJ; Glazebrook KN; Mac Bride MB; Dilaveri CA; Wahner-Roedler DL; Ghosh K; Visscher DW
    Mayo Clin Proc; 2014 Apr; 89(4):536-47. PubMed ID: 24684875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell proliferation in fibrocystic disease and postmenopause breast ducts measured by thymidine labeling.
    Meyer JS; Connor RE
    Cancer; 1982 Aug; 50(4):746-51. PubMed ID: 7093909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology.
    Sloane JP; Ellman R; Anderson TJ; Brown CL; Coyne J; Dallimore NS; Davies JD; Eakins D; Ellis IO; Elston CW
    Eur J Cancer; 1994; 30A(10):1414-9. PubMed ID: 7833094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.